
Anthraquinones and derivatives
Found 404 products of "Anthraquinones and derivatives"
Doxorubicin
CAS:Doxorubicin (Adriamycin) is a Topoisomerase II (Top2) inhibitor with antineoplastic activity.Formula:C27H29NO11Purity:99.31%Color and Shape:Red Crystalline Solid SolidMolecular weight:543.52Daunorubicinol-13C,d3 (mixture of diastereomers)
CAS:Controlled ProductApplications A metabolite of Daunorubicin. Used as an antineoplastic. Complexes with DNA. Inhibits DNA and RNA synthesis.
References Mizuno, N.S., et al.: Cancer Res., 35, 1542 (1975), Munger, C., et al.: Cancer Res., 48, 2404 (1988), Kobayashi, Y., et al.: J. Biol. Chem., 275, 17639 ( 2000), Burke, B., et al.: Cardiovasc. Toxicol., 2, 41 (2002),Formula:CC26D3H28NO10Color and Shape:NeatMolecular weight:533.55Daunomycinone
CAS:Applications Daunomycinone is the main metabolite of Daunorubicin (D194500).
References Hjelle, J.T., et al.: J. Pharmacol. Exp. Therap., 229, 372 (1984); Prikrylova, V., et al.: J. Antibiotics, 38, 1714 (1985)Formula:C21H18O8Color and Shape:RedMolecular weight:398.36Bisacodyl
CAS:Controlled ProductApplications Cathartic.
References Schmidt, et al.: Arzneim.-Forsch., 3, 19 (1953), Wald, A., et al.: J. Clin. Gastroenterol., 36, 386 (2003),Formula:C22H19NO4Color and Shape:NeatMolecular weight:361.39Idarubicinol (Mixture of Diastereomers)
CAS:Stability Hygroscopic
Applications Idarubicinol is the alcohol analog of Idrabucin (I167000), an orally active anthracycline; analog of Daunorubicin. Antineoplastic.
References Arcamone, F., et al.: Caner Treat. Rep., 60, 829 (1976), Zini, G., et al.: Cancer Chemother. Pharmacol., 16, 107 (1986), Gillies, H.C., et al.: Br.J. Clin. Pharmacol., 23, 303 (1987), Villani, F., et al.: Eur. J. Cancer Clin. Oncol., 25, 13 (1989),Formula:C26H29NO9Color and Shape:NeatMolecular weight:499.51Sodium 9,10-dioxo-9,10-dihydroanthracene-2-sulfonate hydrate
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:328.26998901367199,10-dioxo-9,10-dihydroanthracene-2-carbonyl chloride
CAS:Purity:98.0%Molecular weight:270.670013427734414-Bromo, 13-Deoxo, 13,13-Dimethoxy Daunorubicin Hydrobromide (>85%)
CAS:Controlled ProductApplications (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, is the metabolite of Doxorubicin (D558000), which is a neoplasm inhibitor,and an antineoplastic.
References Smith, T.H., et al.: J. Med. Chem., 22, 40 (1979); Di Marco, A., et al.: Cancer Chemother. Rep., (part 1), 53, 33 (1969), Mihich, E. and Ehrke, M.J.: Transplant. Proc., 16, 499 (1984),Formula:C29H34BrNO11·BrHPurity:>85%Color and Shape:NeatMolecular weight:733.49,10-Anhydro-8-desacetyl-8-carboxy Daunorubicin Hydrochloride
Controlled ProductApplications 9,10-Anhydro-8-desacetyl-8-carboxy Daunorubicin is an impurity of Doxorubicin (D558000), an antineoplastic agent.
Formula:C26H26ClNO10Purity:>85%Color and Shape:NeatMolecular weight:547.941-(Methylamino)anthracene-9,10-dione
CAS:Purity:95.0%Color and Shape:Solid, Reddish yellow - Deep yellow red powderMolecular weight:237.25799560546875Bisoxatin
CAS:Bisoxatin (LA 271A) is an oral laxative that can be used to study contact laxatives for chronic constipation.Formula:C20H15NO4Purity:99.47%Color and Shape:SolidMolecular weight:333.34Doxorubicin impurity
CAS:Doxorubicin is an organic compound that belongs to the class of polycyclic aromatic hydrocarbons. It is used as a cancer therapy, primarily in the treatment of breast cancer. The chemical sensing of impurities in doxorubicin can be done using phase transfer methods. The quantification of these impurities can be done using high-performance liquid chromatography (HPLC) or gas chromatography (GC).Formula:C26H27NO11Purity:Min. 90 Area-%Color and Shape:Red PowderMolecular weight:529.49 g/molDaunomycinone
CAS:Daunomycinone is a chemical compound that belongs to the group of antitumor agents. It is used in cancer therapy and has been shown to inhibit protein synthesis, leading to cell death. Daunomycinone can be synthesized by reacting adriamycin with trifluoroacetic acid in the presence of an organic base. This reaction produces a daunomycinone molecule that has a hydroxyl group at one end and a carbonyl group at the other. The binding constants between daunomycinone and human serum proteins have been determined experimentally using molecular modeling techniques. Hydrogen bonding interactions are also present in this complex, which may account for its high affinity for proteins found in human serum.Formula:C21H18O8Purity:Min. 95%Color and Shape:Red PowderMolecular weight:398.36 g/mol2,6-Dihydroxyanthracene-9,10-dione
CAS:Formula:C14H8O4Purity:95%Color and Shape:Solid, Crystalline PowderMolecular weight:240.214



